MLSS MILESTONE SCIENTIFIC

Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or for international callers and by entering the access code: 169295. A webcast and replay of the call may be accessed at Webcast URL: .

An audio replay of the call will be available through Friday, November 29th, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or for international callers and by entering the access code: 51651.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the or visit .

Contact:

Crescendo Communications, LLC

Email:

Tel: 212-671-1020



EN
12/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

 PRESS RELEASE

Milestone Scientific to Present at The Benchmark Company’s Upcoming Di...

Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024 ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its CEO Arjan Haverhals and Chairman Neal Goldman will be presenting at The Benchmark Company’s 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City. Th...

 PRESS RELEASE

Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on...

Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems ROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced its approval on contract for the Federal Supply Schedule (FSS), also known as the GSA Schedule, for the CompuFlo® Epidural System. This significant milestone follows the Company's earli...

 PRESS RELEASE

Milestone Scientific Achieves 22% Increase in Revenue for the Third Qu...

Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter end...

 PRESS RELEASE

Milestone Scientific Announces CEO Transition, with Chairman Neal Gold...

Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support thr...

 PRESS RELEASE

Milestone Scientific Schedules Third Quarter 2024 Financial Results an...

Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments. The conference call will ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch